Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 272,571	$ 504,389
Restricted cash	1,448	3,345
Investments	144,912	3,212
Trade receivables	41,491	29,413
Inventory	23,378	15,791
Prepaid expenses and other current assets	11,053	9,986
Total current assets	494,853	566,136
Property and equipment, net	8,702	8,714
Long-term investments	0	6,829
Other assets	6,983	6,472
Total assets	510,538	588,151
Liabilities and Stockholders’ Deficit
Accounts payable	12,024	27,808
Accrued expenses	79,711	72,670
Deferred revenue	1,521	1,421
Lease financing obligation	2,134	1,819
Total current liabilities	95,390	103,718
Lease financing obligation	6,198	5,962
Royalty financing obligations	477,666	449,375
Secured term loan	144,516	136,082
Stockholders’ equity:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 185,876 as of June 30, 2022 and 184,350 as of December 31, 2021	1,859	1,843
Additional paid-in capital	1,125,453	1,098,498
Accumulated other comprehensive income	15	177
Accumulated deficit	(1,340,559)	(1,207,504)
Total stockholders’ deficit	(213,232)	(106,986)
Total liabilities and stockholders’ deficit	$ 510,538	$ 588,151